ML

Mark D. Lindner

CY Cytotherapeutics: 5 patents #11 of 38Top 30%
NS Neurotech S.A.: 1 patents #24 of 44Top 55%
Overall (All Time): #883,918 of 4,157,543Top 25%
6
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
6264941 Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules Edward E. Baetge, Joseph P. Hammang, Frank T. Gentile, Shelley R. Winn, Dwaine F. Emerich 2001-07-24
5908623 Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules Edward E. Baetge, Joseph P. Hammang, Frank T. Gentile, Shelley R. Winn, Dwaine F. Emerich 1999-06-01
5676943 Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules Edward E. Baetge, Joseph P. Hammang, Frank T. Gentile, Shelley R. Winn, Dwaine F. Emerich 1997-10-14
5656481 Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules Edward E. Baetge, Joseph P. Hammang, Frank T. Gentile, Shelley R. Winn, Dwaine F. Emerich 1997-08-12
5653975 Compositions and methods for the delivery of biologically active molecules using cells contained in biocompatible capsules Edward E. Baetge, Joseph P. Hammang, Frank T. Gentile, Shelley R. Winn, Dwaine F. Emerich 1997-08-05
5639275 Delivery of biologically active molecules using cells contained in biocompatible immunoisolatory capsules Edward E. Baetge, Joseph P. Hammang, Frank T. Gentile, Shelley R. Winn, Dwaine F. Emerich 1997-06-17